Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen
Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen Published: May 18, 2022 By Alex Keown BioSpace With increasing concerns
Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen Published: May 18, 2022 By Alex Keown BioSpace With increasing concerns
COVID is rising in the Americas, virus ‘not going away anytime soon’ – PAHO May 18, 2022; 12:16 PM EDT By Gabriel Araujoand Steven Grattan SAO
As U.S. COVID-19 cases rise, so does demand for antivirals May 17, 2022; 4:12 PM EDT (Updated 6:15 PM EDT) By Ahmed Aboulenein WASHINGTON, May
FDA authorizes COVID-19 boosters for kids 5-11 as cases creep up Published: May 17, 2022 (Updated) By Vanessa Doctor, RN BioSpace On Tuesday
Lacking vaccines, North Korea battles COVID with antibiotics, home remedies May 16, 2022; 11:03 AM EDT By Sunghyuk An and Heejung Jung SEOUL, May
Shanghai targets June COVID lockdown exit as China economy slumps May 16, 2022, 8:23 AM EDT By Brenda Goh and Kevin Yao SHANGHAI/BEIJING, May 16
Texas doctor calls U.S. COVID deaths nearing 1 million ‘mindblowing’ May 10, 2022, 6:07 AM EDT By Callaghan O’hare HOUSTON, May 10 (Reuters)
Shanghai tightens lockdown to hit zero-COVID goal by late May May 8, 2022; 3:55 AM EDT SHANGHAI, May 8 (Reuters) – Shanghai is tightening its
COVID Americas cases up, N. American cases up for 5th week – PAHO May 4, 2022, 11:36 AM EDT By Gabriel Araujo and Steven Grattan SAO PAULO,
Setback for Shanghai’s COVID battle as Beijing ramps up mass testing May 2, 2022; 8:37 AM EDT By Brenda Goh and Sophie Yu SHANGHAI/BEIJING, May 2
India’s COVID infections hit month-high, one state reports spike in deaths April 18, 2022; 5:37 AM EDT NEW DELHI, April 18 (Reuters) – India’s
WHO says it is analyzing two new Omicron COVID sub-variants Published April 11, 2022, 9:43 AM EDT By Jennifer Rigby (Reuters) – The World Health
FDA pulls authorization for GSK-Vir’s COVID therapy as BA.2 cases rise April 5, 2022; 7:12 PM EDT (Reuters) – The U.S. health regulator said on
Omicron sub-variant BA.2 makes up 72% of COVID variants in U.S. – CDC April 4, 2022; 6:13 PM EDT (Reuters) – The U.S. national public health
Omicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. – CDC March 29, 2022; 11:07 AM EDT (Reuters) – The U.S. national public